| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Bolt Biotherapeutics, Inc. | - | 6.2% | EDGAR |
| SC 13G/A | 2024-02-14 | TANG CAPITAL PARTNERS LP | Bolt Biotherapeutics, Inc. | 3,652,244 | 9.6% | EDGAR |
| SC 13G/A | 2024-02-13 | Vivo Capital VIII, LLC | Bolt Biotherapeutics, Inc. | 1,821,483 | 4.8% | EDGAR |
| SC 13D/A | 2024-02-12 | Pivotal bioVenture Partners Fund I, L.P. | Bolt Biotherapeutics, Inc. | 3,058,419 | 8.1% | EDGAR |
| SC 13G | 2023-04-20 | TANG CAPITAL PARTNERS LP | Bolt Biotherapeutics, Inc. | 2,732,250 | 7.2% | EDGAR |
| SC 13G/A | 2023-02-14 | CITADEL ADVISORS LLC | Bolt Biotherapeutics, Inc. | - | 7.3% | EDGAR |
| SC 13G/A | 2023-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | Bolt Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-01-04 | Novo Holdings A/S | Bolt Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-12-28 | Novo Holdings A/S | Bolt Biotherapeutics, Inc. | 2,534,465 | 6.7% | EDGAR |
| SC 13D/A | 2022-09-30 | Novo Holdings A/S | Bolt Biotherapeutics, Inc. | 3,703,991 | 9.8% | EDGAR |
| SC 13D/A | 2022-07-15 | Novo Holdings A/S | Bolt Biotherapeutics, Inc. | 3,703,991 | 9.8% | EDGAR |
| SC 13G/A | 2022-05-16 | RA CAPITAL MANAGEMENT, L.P. | Bolt Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | CITADEL ADVISORS LLC | Bolt Biotherapeutics, Inc. | - | 7.5% | EDGAR |
| SC 13G | 2021-11-29 | SUVRETTA CAPITAL MANAGEMENT, LLC | Bolt Biotherapeutics, Inc. | 2,230,250 | 6.0% | EDGAR |
| SC 13D/A | 2021-11-22 | Novo Holdings A/S | Bolt Biotherapeutics, Inc. | 4,503,991 | 12.0% | EDGAR |
| SC 13D/A | 2021-08-13 | Pivotal bioVenture Partners Fund I, L.P. | Bolt Biotherapeutics, Inc. | 3,058,419 | 8.4% | EDGAR |
| SC 13G | 2021-04-07 | RA CAPITAL MANAGEMENT, L.P. | Bolt Biotherapeutics, Inc. | 2,378,325 | 6.5% | EDGAR |
| SC 13G | 2021-02-19 | CITADEL ADVISORS LLC | Bolt Biotherapeutics, Inc. | - | 8.1% | EDGAR |
| SC 13G | 2021-02-18 | Vivo Capital VIII, LLC | Bolt Biotherapeutics, Inc. | 2,273,005 | 6.6% | EDGAR |
| SC 13D | 2021-02-17 | Pivotal bioVenture Partners Fund I, L.P. | Bolt Biotherapeutics, Inc. | 1,891,467 | 5.5% | EDGAR |